Methods, reagents and cells for biosynthesizing compounds

US9816117B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9816117-B2
Application numberUS-201514741228-A
CountryUS
Kind codeB2
Filing dateJun 16, 2015
Priority dateJun 16, 2014
Publication dateNov 14, 2017
Grant dateNov 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This document describes biochemical pathways for producing 6-hydroxyhexanoate methyl ester and hexanoic acid hexyl ester using one or more of a fatty acid O-methyltransferase, an alcohol O-acetyltransferase and a monooxygenase, as well as recombinant hosts expressing one or more of such enzymes. 6-hydroxyhexanoate methyl esters and hexanoic acid hexyl ester can be enzymatically converted to adipic acid, adipate semialdehyde, 6-aminohexanoate, 6-hydroxyhexanoate, hexamethylenediamine, and 1,6-hexanediol.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of producing a terminal hydroxyl (C 3-8 hydroxyalkyl)-C(═O)OCH 3 ester in a recombinant host, said method comprising: a) enzymatically converting a C 4-9 carboxylic acid to a (C 3-8 alkyl)-C(═O)OCH 3 ester using a polypeptide having fatty acid O-methyltransferase activity classified under EC 2.1.1.15; and b) enzymatically converting the (C 3-8 alkyl)-C(═O)OCH 3 ester to a terminal hydroxyl (C 3-8 hydroxyalkyl)-C(═O)OCH 3 ester using a polypeptide having monooxygenase activity classified under EC 1.14.14.- or EC 1.14.15.-, wherein the C 4-9 carboxylic acid is enzymatically produced from a C 4-9 alkanoyl-CoA using: a polypeptide having thioesterase activity classified under EC 3.1.2.-; or a polypeptide having butanal dehydrogenase activity classified under EC 1.2.1.10 or EC 1.2.1.57 and a polypeptide having aldehyde dehydrogenase activity classified under EC 1.2.1.3 or EC 1.2.1.4. 2. The method of claim 1 , said method further comprising enzymatically converting the terminal hydroxyl (C 3-8 hydroxyalkyl)-C(═O)OCH 3 ester to a terminal hydroxyl C 4-9 hydroxyalkanoate using a polypeptide having demethylase activity classified under EC 2.1.1.- and/or a polypeptide having esterase activity classified under EC 3.1.1.-. 3. The method of claim 1 , wherein C 4-9 carboxylic acid is hexanoate, and is enzymatically converted to hexanoate methyl ester; and the hexanoate methyl ester is enzymatically converted to 6-hydroxyhexanoate methyl ester. 4. The method of claim 1 , wherein the C 4-9 alkanoyl-CoA is hexanoyl-CoA, and hexanoate is enzymatically produced from hexanoyl-CoA. 5. The method of claim 3 , said method further comprising enzymatically converting 6-hydroxyhexanoate methyl ester to 6-hydroxyhexanoate using a polypeptide having demethylase activity classified under EC 2.1.1.- or a polypeptide having esterase activity classified under EC 3.1.1.-. 6. The method of claim 4 , wherein hexanoyl-CoA is produced from acetyl-CoA via two cycles of CoA-dependent carbon chain elongation, wherein each of said two cycles of CoA-dependent carbon chain elongation comprises using (i) a polypeptide having β-ketothiolase activity classified under EC 2.3.1.9, EC 2.3.1.16, or EC 2.3.1.174 or a polypeptide having acetyl-CoA carboxylase activity classified under EC 6.4.1.2 and a polypeptide having acetoacetyl-CoA synthase activity classified under EC 2.3.1.194, (ii) a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity classified under EC 1.1.1.35, EC 1.1.1.36, or EC 1.1.1.157 or a polypeptide having 3-oxoacyl-CoA reductase activity classified under EC 1.1.1.100, (iv) a polypeptide having enoyl-CoA hydratase activity classified under EC 4.2.1.17 or EC 4.2.1.119, and (v) a polypeptide having trans-2-enoyl-CoA reductase activity classified under EC 1.3.1.8, EC 1.3.1.38, or EC 1.3.1.44 to form hexanoyl-CoA from acetyl-CoA. 7. A method of enzymatically producing 6-hydroxyhexanoate, the method comprising: a) enzymatically converting hexanoate to hexanoate methyl ester using a polypeptide having fatty acid O-methyltransferase activity classified under EC 2.1.1.15; b) enzymatically converting hexanoate methyl ester to 6-hydroxyhexanoate methyl ester using a polypeptide having monooxygenase activity classified under EC 1.14.14.- or EC 1.14.15.-; and c) enzymatically converting 6-hydroxyhexanoate methyl ester to 6-hydroxyhexanoate using a polypeptide having demethylase activity classified under EC 2.1.1.- or a polypeptide having esterase activity classified under EC 3.1.1.-. 8. The method of claim 1 , wherein said recombinant host is subjected to a cultivation strategy under aerobic, anaerobic or, micro-aerobic cultivation conditions. 9. The method of claim 8 , wherein said recombinant host is cultured under conditions of nutrient limitation. 10. The method of claim 8 , wherein said recombinant host is retained using a ceramic membrane to maintain a high cell density during fermentation. 11. The method of claim 8 , wherein the principal carbon source fed to the recombinant host derives from a biological feedstock. 12. The method of claim 11 , wherein the biological feedstock is, or derives from, monosaccharides, disaccharides, lignocellulose, hemicellulose, cellulose, lignin, levulinic acid, formic acid, triglycerides, glycerol, fatty acids, agricultural waste, condensed distillers' solubles, or municipal waste. 13. The method of claim 8 , wherein the principal carbon source fed to the recombinant host derives from a non-biological feedstock. 14. The method of claim 13 , wherein the non-biological feedstock is, or derives from, natural gas, syngas, CO 2 /H 2 , methanol, ethanol, benzoate, non-volatile residue (NVR) caustic wash waste stream from cyclohexane oxidation processes, or terephthalic acid/isophthalic acid mixture waste streams. 15. The method of claim 9 , wherein the recombinant host is a prokaryote selected from Escherichia, Clostridia, Corynebacteria, Cupriavidus, Pseudomonas, Delftia, Bacillus, Lactobacillus, Lactococcus , and Rhodococcus , or a eukaryote selected from Aspergillus, Saccharomyces, Pichia, Yarrowia, Issatchenkia, Debaryomyces, Arxula , and Kluveromyces. 16. The method of claim 3 , wherein the polypeptide having fatty acid O-methyltransferase activity classified under EC 2.1.1.15 has at least 85% sequence identity to an amino acid sequence set forth in SEQ ID NO:22, SEQ ID NO:23, or SEQ ID NO:24; and the polypeptide having monooxygenase activity classified under EC 1.14.14.- or EC 1.14.15.- has at least 85% sequence identity to an amino acid sequence set forth in SEQ ID NO: 13-15, SEQ ID NO:27 or SEQ ID NO:28. 17. The method of claim 4 , wherein the polypeptide having thioesterase activity classified under EC 3.1.2.- has at least 85% sequence identity to the amino acid sequence set forth in SEQ ID NO:1, SEQ ID NO:32, or SEQ ID NO:33. 18. The method of claim 5 , wherein the polypeptide having demethylase activity classified under EC 2.1.1.- has at least 85% sequence identity to the amino acid sequence set forth in SEQ ID NO: 30 or SEQ ID NO: 31 and the polypeptide having esterase activity classified under EC 3.1.1.- has at least 85% sequence identity to the amino acid sequence set forth in SEQ ID NO: 26. 19. The method of claim 8 , wherein said recombinant host is cultured under conditions of phosphate, nitrogen, or oxygen limitation.

Assignees

Inventors

Classifications

  • Fatty acids · CPC title

  • 5-Aminovalerate transaminase (2.6.1.48) · CPC title

  • C12N9/1096Primary

    transferring nitrogenous groups (2.6) · CPC title

  • Beta-alanine-pyruvate transaminase (2.6.1.18) · CPC title

  • Carboxylate reductase (1.2.99.6) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9816117B2 cover?
This document describes biochemical pathways for producing 6-hydroxyhexanoate methyl ester and hexanoic acid hexyl ester using one or more of a fatty acid O-methyltransferase, an alcohol O-acetyltransferase and a monooxygenase, as well as recombinant hosts expressing one or more of such enzymes. 6-hydroxyhexanoate methyl esters and hexanoic acid hexyl ester can be enzymatically converted to adi…
Who is the assignee on this patent?
Invista North America S Á R L, Invista North America Sarl
What technology area does this patent fall under?
Primary CPC classification C12N9/1096. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).